Page last updated: 2024-08-21

congo red and Cognition Disorders

congo red has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruys, E; Rofina, JE; Secrève, M; Toussaint, MJ; van der Meer, I; van der Spek, A; van Ederen, AM; Van Eerdenburg, FJ1
Morton, AJ; Pallier, PN; Wanderer, J; Wood, NI1

Other Studies

2 other study(ies) available for congo red and Cognition Disorders

ArticleYear
Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease.
    Brain research, 2006, Jan-19, Volume: 1069, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Aging; Aldehydes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Atrophy; Behavior, Animal; Cerebral Cortex; Cognition Disorders; Congo Red; Demyelinating Diseases; Deoxyguanosine; Disease Models, Animal; Dogs; Female; Immunohistochemistry; Lipofuscin; Male; Statistics, Nonparametric

2006
Systemic administration of Congo red does not improve motor or cognitive function in R6/2 mice.
    Neurobiology of disease, 2007, Volume: 25, Issue:2

    Topics: Animals; Blood-Brain Barrier; Body Weight; Brain; Cognition; Cognition Disorders; Congo Red; Dyskinesias; Female; Humans; Huntington Disease; Inclusion Bodies; Locomotion; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neurons; Neuroprotective Agents; Recovery of Function; Treatment Failure

2007